High impact information on omega-Aminoarginine

• The NO synthase (NOS) activity was very high in the lysate of IRBC (while not measurable in that of normal red blood cells) and was inhibited in a dose-dependent way by three different NOS inhibitors (L-canavanine, NG-amino-L-arginine, and NG-nitro-L-arginine) [1].
• NO synthase inhibitor NG-amino-L-arginine (L-NAA) was found to markedly enhance MCP-1 and PDGF-A expression induced by step flow, but decrease their expression induced by impulse flow, in a dose-dependent manner [2].
• NMDA-evoked release of [3H]GABA from striatal slices were insensitive to exogenous NO donors, but NG-nitro- and NG-amino-L-arginine produced 100% increases [3].
• DAG inactivates both the NADPH-oxidase and the citrulline-forming activities of GH3 pituitary nNOS while NG-amino-L-arginine inactivates only its citrulline-forming activity [4].
• This compound did not affect the transport of L-arginine (L-Arg) into synaptosomes at concentrations up to 100 microM but other potential inhibitors of NOS (NG-monomethyl-L-arginine, NG-amino-L-arginine and L-arginine methyl ester) inhibited L-Arg transport at a concentration < 5 microM [5].

Associations of omega-Aminoarginine with other chemical compounds

• Flow-induced NO production was blocked by the NO synthase (NOS) inhibitor NG-amino-L-arginine, but not by dexamethasone, which suggests that the flow stimulated a constitutive NOS isoform [6].

References